Lewy body pathology in Alzheimer’s disease

@article{Kotzbauer2007LewyBP,
  title={Lewy body pathology in Alzheimer’s disease},
  author={Paul T Kotzbauer and John Q. Trojanowski and Virginia M. -Y. Lee},
  journal={Journal of Molecular Neuroscience},
  year={2007},
  volume={17},
  pages={225-232}
}
Lewy bodies, the characteristic pathological lesion of substantia nigra neurons in Parkinson’s disease (PD), are frequently observed to accompany the amyloid plaque and neurofibrillary tangle pathology of Alzheimer’s disease (AD). However the typical anatomic distribution of Lewy bodies in AD is distinct from PD. The most common site of occurrence is the amygdala, where Lewy bodies are observed in approximately 60% of both sporadic and familial AD. Other common sites of occurrence include the… 
Milestones in Parkinson's disease—Clinical and pathologic features
TLDR
The identification of the widespread deposition of fibrillized α‐synuclein in Lewy bodies and Lewy neurites in the brains of patients with Parkinson's disease in 1997 has had a profound impact on how the disease is now conceptualized, and advances have progressed to a stage where the preclinical stages of Parkinson's Disease and its specific signs and symptoms are being predicted and tested clinically.
Clinical Features of Alzheimer Disease With and Without Lewy Bodies.
TLDR
It is found that participants with both AD and Lewy body pathology have a clinical phenotype that may be distinguished from AD alone, and the frequency ofLewy bodies in AD and the association of Lewy bodies with the APOE ε4 allele suggest potential common mechanisms for AD andLewy body pathologies.
100 years of Lewy pathology
TLDR
The relevance of Lewy's discovery 100 years ago for the current understanding of PD and related disorders is reviewed.
Cognitive status correlates with neuropathologic stage in Parkinson disease
TLDR
The decrease in median Mini-Mental State Examination scores between PD stages 3 to 6 indicates that the risk of developing dementia increases with disease progression, and in some individuals, cognitive decline can develop in the presence of mild Parkinson disease–related cortical pathology and, conversely, widespread cortical lesions do not necessarily lead to cognitive decline.
The Genetics of Dementia with Lewy Bodies: Current Understanding and Future Directions
TLDR
Although off to a slow start, recent studies have reinvigorated the field of DLB genetics and these results enable us to start to have a more complete understanding of the genetic architecture of this disease.
Alzheimer's disease a century later.
TLDR
There remains an unmet urgent need to identify effective primary and secondary prevention therapies in order to avert a financially overwhelming public health problem.
...
...

References

SHOWING 1-10 OF 113 REFERENCES
Dementia with Lewy Bodies
TLDR
Current clinical, genetic, and pathological DLB data is reviewed and directions for future research are indicated, including mutations in the alpha-synuclein gene, which appears to be responsible for autosomal dominant PD in several kindreds.
Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer’s disease and Lewy body disorders
TLDR
The results indicate that the amygdala is severely affected by the accumulation of both neurofibrillary tangles (NFTs) and LBs in most cases of the diseases mentioned above, and that amygdala LBs have a similar epitope composition to that ofLBs in the brain stem and cerebral cortex.
α-Synuclein in Lewy bodies
TLDR
Strong staining of Lewy bodies from idiopathic Parkinson's disease with antibodies for α-synuclein, a presynaptic protein of unknown function which is mutated in some familial cases of the disease, indicates that the LewY bodies from these two diseases may have identical compositions.
Clinical and Neuropathological Correlates of Dementia with Lewy Bodies
TLDR
Dementia with Lewy bodies is characterized by a specific neuroanatomical vulnerability to LB pathology, distinct from AD pathology, with a complicated relationship to clinical symptoms.
The Lewy-Body Variant of Alzheimer's Disease
TLDR
It is concluded that the differential diagnosis of LB dementia should be considered in patients satisfying NINCDS-ADRDA criteria for Alzheimer-type dementia who show marked Parkinsonian features and a frontal accentuation of cerebral atrophy.
Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease
TLDR
CLBs detected by α-synuclein antibodies in patients with PD are a more sensitive and specific correlate of dementia than the presence of Alzheimer’s pathology, which was present in a minority of the cases in this series.
The Lewy body variant of Alzheimer's disease
TLDR
The patients with LBs appeared to constitute a distinct neuropathologic and clinical subset of AD, the Lewy body variant (LBV), and there was an increase in essential tremor, bradykinesia, mild neck rigidity, and slowing of rapid alternating movements in the LBV group.
Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
TLDR
Antisera to the N terminus and the NAC domain of the alpha-synuclein protein were employed to elucidate the expression pattern in brains of patients with AD, PD, DLB and control specimen and suggest that alpha- Synuclein does not contribute to late neurodegenerative processes in AD brains.
...
...